Earnings History Data for LogicBio Therapeutics (LOGC) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
LogicBio Therapeutics
LogicBio Therapeutics Inc. is a genome editing company. It focuses on developing medicines to treat rare diseases in patients with significant unmet medical needs. The company's technology platform consists of GeneRide(TM). LogicBio Therapeutics Inc. is based in Cambridge, Massachusetts.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2022 | PM | 7:05 AM ET (Nov 14) |
LOGC | LogicBio Therapeutics | 68.00 | -0.18 | -0.20 | 0.00 | LogicBio GAAP EPS of -$0.18 beats by $0.02, revenue of $2.72M beats by $0.72M [11/14/2022 9:13 AM] |
2.07 | 0.0 (0.00%) |
2.06 | -0.01 (-0.48%) |
0.26 - 3.77 | 207,717 | 250,000 | 3,072 | |
| 04-03-2022 | AH | LOGC | LogicBio Therapeutics | 24.00 | -0.28 | -0.31 | 0.00 | LogicBio GAAP EPS of -$1.24 beats by $0.08, revenue of $5.41M beats by $0.56M [3/4/2022 4:13 PM] |
0.6801 | 0.03 (4.18%) |
0.67 | 0.02 (2.63%) |
0.60 - 8.58 | 222,492 | 210,000 | 7,702 | ||
| 10-05-2021 | PM | LOGC | LogicBio Therapeutics, Inc. | 175.60 | -0.32 | -0.28 | -0.41 | LogicBio EPS misses by $0.06, beats on revenue [5/10/2021 7:55 AM] |
4.66 | -0.17 (-3.52%) |
4.86 | 0.03 (0.62%) |
4.51 - 10.00 | 157,282 | 180,000 | 741 | ||
| 15-03-2021 | AH | LOGC | LogicBio Therapeutics, Inc. | 242.85 | -0.19 | -0.39 | -0.50 | LogicBio EPS misses by $0.03, beats on revenue [3/15/2021 5:46 PM] |
8.50 | 0.32 (3.91%) |
8.49 | 0.33 (4.04%) |
4.01 - 10.00 | 92,786 | 129,396 | 416 | ||
| 09-11-2020 | PM | LOGC | LogicBio Therapeutics, Inc. | 193.60 | -0.34 | -0.43 | -0.48 | LogicBio reports Q3 results [11/9/2020 6:37 AM] |
6.09 | -0.23 (-3.64%) |
6.25 | -0.07 (-1.11%) |
3.05 - 11.60 | 81,396 | 112,981 | 368 | ||
|
|
||||||||||||||||||
| 10-08-2020 | PM | LOGC | LogicBio Therapeutics, Inc. | 184.19 | -0.35 | -0.53 | -0.45 | LogicBio EPS beats by $0.13 [8/10/2020 6:42 AM] |
8.34 | 0.06 (0.72%) |
8.62 | 0.36 (4.36%) |
3.05 - 14.00 | 20,027 | 57,810 | 131 | ||
|
|
||||||||||||||||||
| 11-05-2020 | AH | LOGC | LogicBio Therapeutics, Inc. | 170.26 | -0.41 | -0.48 | -0.34 | LogicBio EPS beats by $0.07 [5/11/2020 4:59 PM] |
6.07 | -0.61 (-9.13%) |
0.0 | 0.0 (0.00%) |
3.05 - 20.07 | 50,635 | 62,637 | 0 | ||
|
|
||||||||||||||||||